Business
DECN Enters into Strategic Agreement with Paragon Sales and Marketing Inc. for Big Box Sales to Walmart, CVS, Walgreens, Costco and Cardinal Health
DECN Enters into Strategic Agreement with Paragon Sales and Marketing Inc. for Big Box Sales to Walmart, CVS, Walgreens, Costco and Cardinal Health.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"Company Moves to Next Step, Builds Foundation for Increased Revenues, Branding And Positioning, as Well as a Handsome Settlement or M&A TransactionLOS ANGELES, CA / ACCESSWIRE / March 12, 2019 / Decision Diagnostics Corp. (OTC PINK: DECN) Decision Diagnostics Corp. is a 16 year old diabetes focused bio-technology R&D firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for a growing brand of alternatives to legacy diabetic, proprietary, and pet testing glucose test strips.Decision Diagnostics is pleased to announce and communicate that we have recently entered into a long term relationship with PARAGON Sales and Marketing Inc. to support the national growth of both our branded and private label retail products sold under our "Gen" brand, and our private label brands of Alltara!, ConsumerValue!, Infatig!, and Medicius!. Initial accounts that we have assigned to PARAGON for big box and private brand big box agreements include Walmart, CVS, Walgreens, Costco and Cardinal Health. PARAGON will also work closely with us in evaluating other potential new retail product categories and products that we may launch in both branded and private label offerings in the future.Keith Berman, CEO of DECN commented, "Now that we have established our "Gen" technologies to the stage where we can comfortably direct our focus to the more traditional sales channels. Although never absent from our planning and operations, many intended activities and associations were held in abeyance until were confident that our "Gen" brand had been fully accepted in the market and our pricing structure stable. With our market prices now on the upswing we no longer now need to be restrained. We are beginning a full scale frontal assault on the domestic retail market immediately starting with the world's largest retailer, who by the way is already a customer.The four year agreement with PARAGON charges them with executing and managing DECN's existing massive retail contract; completing negotiations and finalizing agreements in varied degrees of completion; introducing the company's "Gen" family of diabetic test stripsto unexplored retail venues, and pursuing opportunities in newretail markets."Chuck...